Delivery Order SPE2DR25D1104-SPE2DR26FL078
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,367.44 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was awarded on January 6, 2026, with an ultimate completion date of January 28, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $63,705.00 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside restrictions and carries a firm fixed-price structure, with performance scheduled for completion by February 12, 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,822.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 18, 2026. The products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,548.22 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The order was issued on January 23, 2026, with an ultimate completion date of February 13, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with an ultimate completion date of February 20, 2026. This firm fixed-price, non-set-aside contract was awarded on January 29, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, effective January 7, 2026, with an ultimate completion date of January 29, 2026, represents a firm fixed-price procurement with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $49,597.50 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency has awarded a delivery order valued at $1,012.19 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of January 12, 2026. The vaccine will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,367.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of January 29, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a...
- The Defense Logistics Agency awarded a delivery order valued at $6,370.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by February 5, 2026. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a task order against AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL078Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, which carries a firm fixed price structure, was competitively awarded without a set-aside designation and is scheduled for completion by February 20, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide range of pharmaceutical products across multiple therapeutic domains through competitive procurement processes. This specific vaccine order supports the Defense Logistics Agency's mission to supply essential medical commodities to military treatment facilities and other federal healthcare institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/28/26 |